What is the projected market valuation of the Neuroscience Market by 2035?

The projected market valuation by 2035 is 58.76 USD Billion. Read More

What was the overall market valuation of the market in 2024?

The overall market valuation of the Neuroscience Market in 2024 was 36.9 USD Billion. Read More

What is the expected CAGR for the Neuroscience Market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 4.32%. Read More

Which companies are considered key players in the Neuroscience Market?

Key players include Eli Lilly and Company, Pfizer Inc., Johnson & Johnson, Novartis AG, and others. Read More

What are the main segments of the Neuroscience Market?

The main segments of the market include Neuroscience Technique, Application, End-User, and Product. Read More

How much is the Neuroimaging segment projected to grow by 2035?

The Neuroimaging segment is projected to grow from 8.0 USD Billion in 2024 to 12.0 USD Billion by 2035. Read More

What is the projected valuation for the Psychiatry application by 2035?

The projected valuation for the Psychiatry application is expected to rise from 10.0 USD Billion in 2024 to 15.0 USD Billion by 2035. Read More

What is the expected growth for MRI Systems in the Neuroscience Market?

MRI Systems are expected to grow from 8.0 USD Billion in 2024 to 12.0 USD Billion by 2035. Read More

Which end-user segment is projected to have the highest valuation by 2035?

The Pharmaceutical Companies end-user segment is projected to have the highest valuation, increasing from 10.0 USD Billion in 2024 to 18.0 USD Billion by 2035. Read More

What is the anticipated growth for Computational Neuroscience by 2035?

Computational Neuroscience is anticipated to grow from 10.9 USD Billion in 2024 to 19.76 USD Billion by 2035. Read More

Neuro-science Market

ID: MRFR/HC/21154-HCR

100 Pages

Satyendra Maurya

Last Updated: April 20, 2026

Neuroscience Market Research Report: Size, Share, Trend Analysis By Neuroscience Technique (Neuroimaging, Electrophysiology, Behavioral Neuroscience, Neurogenetics, Computational Neuroscience), By Applications (Neurology, Psychiatry, Addiction Treatment, Drug Discovery, Neuromarketing), By End-User (Hospitals & Clinics, Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Educational Institutions), By Product (MRI Systems, CT Scanners, PET Scanners, EEG Systems, EMG Systems) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Neuroscience Technique (USD Billion) | |
  1. 4.1.1 Neuroimaging | |
  2. 4.1.2 Electrophysiology | |
  3. 4.1.3 Behavioral Neuroscience | |
  4. 4.1.4 Neurogenetics | |
  5. 4.1.5 Computational Neuroscience |
2. 4.2 Healthcare, BY Application (USD Billion) | |
  1. 4.2.1 Neurology | |
  2. 4.2.2 Psychiatry | |
  3. 4.2.3 Addiction Treatment | |
  4. 4.2.4 Drug Discovery | |
  5. 4.2.5 Neuromarketing |
3. 4.3 Healthcare, BY End-User (USD Billion) | |
  1. 4.3.1 Hospitals Clinics | |
  2. 4.3.2 Research Institutions | |
  3. 4.3.3 Pharmaceutical Companies | |
  4. 4.3.4 Biotechnology Companies | |
  5. 4.3.5 Educational Institutions |
4. 4.4 Healthcare, BY Product (USD Billion) | |
  1. 4.4.1 MRI Systems | |
  2. 4.4.2 CT Scanners | |
  3. 4.4.3 PET Scanners | |
  4. 4.4.4 EEG Systems | |
  5. 4.4.5 EMG Systems |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Eli Lilly and Company (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Pfizer Inc. (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Johnson & Johnson (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Novartis AG (CH) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Bristol-Myers Squibb Company (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 AstraZeneca PLC (GB) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Roche Holding AG (CH) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Sanofi S.A. (FR) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Merck & Co., Inc. (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
7. 6.4 US MARKET ANALYSIS BY APPLICATION |
8. 6.5 US MARKET ANALYSIS BY END-USER |
9. 6.6 US MARKET ANALYSIS BY PRODUCT |
10. 6.7 CANADA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
12. 6.9 CANADA MARKET ANALYSIS BY END-USER |
13. 6.10 CANADA MARKET ANALYSIS BY PRODUCT |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
16. 6.13 GERMANY MARKET ANALYSIS BY APPLICATION |
17. 6.14 GERMANY MARKET ANALYSIS BY END-USER |
18. 6.15 GERMANY MARKET ANALYSIS BY PRODUCT |
19. 6.16 UK MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
20. 6.17 UK MARKET ANALYSIS BY APPLICATION |
21. 6.18 UK MARKET ANALYSIS BY END-USER |
22. 6.19 UK MARKET ANALYSIS BY PRODUCT |
23. 6.20 FRANCE MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
24. 6.21 FRANCE MARKET ANALYSIS BY APPLICATION |
25. 6.22 FRANCE MARKET ANALYSIS BY END-USER |
26. 6.23 FRANCE MARKET ANALYSIS BY PRODUCT |
27. 6.24 RUSSIA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
28. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION |
29. 6.26 RUSSIA MARKET ANALYSIS BY END-USER |
30. 6.27 RUSSIA MARKET ANALYSIS BY PRODUCT |
31. 6.28 ITALY MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
32. 6.29 ITALY MARKET ANALYSIS BY APPLICATION |
33. 6.30 ITALY MARKET ANALYSIS BY END-USER |
34. 6.31 ITALY MARKET ANALYSIS BY PRODUCT |
35. 6.32 SPAIN MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
36. 6.33 SPAIN MARKET ANALYSIS BY APPLICATION |
37. 6.34 SPAIN MARKET ANALYSIS BY END-USER |
38. 6.35 SPAIN MARKET ANALYSIS BY PRODUCT |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY END-USER |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PRODUCT |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
45. 6.42 CHINA MARKET ANALYSIS BY APPLICATION |
46. 6.43 CHINA MARKET ANALYSIS BY END-USER |
47. 6.44 CHINA MARKET ANALYSIS BY PRODUCT |
48. 6.45 INDIA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
49. 6.46 INDIA MARKET ANALYSIS BY APPLICATION |
50. 6.47 INDIA MARKET ANALYSIS BY END-USER |
51. 6.48 INDIA MARKET ANALYSIS BY PRODUCT |
52. 6.49 JAPAN MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
53. 6.50 JAPAN MARKET ANALYSIS BY APPLICATION |
54. 6.51 JAPAN MARKET ANALYSIS BY END-USER |
55. 6.52 JAPAN MARKET ANALYSIS BY PRODUCT |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY END-USER |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PRODUCT |
60. 6.57 MALAYSIA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
61. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION |
62. 6.59 MALAYSIA MARKET ANALYSIS BY END-USER |
63. 6.60 MALAYSIA MARKET ANALYSIS BY PRODUCT |
64. 6.61 THAILAND MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
65. 6.62 THAILAND MARKET ANALYSIS BY APPLICATION |
66. 6.63 THAILAND MARKET ANALYSIS BY END-USER |
67. 6.64 THAILAND MARKET ANALYSIS BY PRODUCT |
68. 6.65 INDONESIA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
69. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION |
70. 6.67 INDONESIA MARKET ANALYSIS BY END-USER |
71. 6.68 INDONESIA MARKET ANALYSIS BY PRODUCT |
72. 6.69 REST OF APAC MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
73. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION |
74. 6.71 REST OF APAC MARKET ANALYSIS BY END-USER |
75. 6.72 REST OF APAC MARKET ANALYSIS BY PRODUCT |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
78. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION |
79. 6.76 BRAZIL MARKET ANALYSIS BY END-USER |
80. 6.77 BRAZIL MARKET ANALYSIS BY PRODUCT |
81. 6.78 MEXICO MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
82. 6.79 MEXICO MARKET ANALYSIS BY APPLICATION |
83. 6.80 MEXICO MARKET ANALYSIS BY END-USER |
84. 6.81 MEXICO MARKET ANALYSIS BY PRODUCT |
85. 6.82 ARGENTINA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
86. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION |
87. 6.84 ARGENTINA MARKET ANALYSIS BY END-USER |
88. 6.85 ARGENTINA MARKET ANALYSIS BY PRODUCT |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END-USER |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END-USER |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT |
102. 6.99 REST OF MEA MARKET ANALYSIS BY NEUROSCIENCE TECHNIQUE |
103. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION |
104. 6.101 REST OF MEA MARKET ANALYSIS BY END-USER |
105. 6.102 REST OF MEA MARKET ANALYSIS BY PRODUCT |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY NEUROSCIENCE TECHNIQUE, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY NEUROSCIENCE TECHNIQUE, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY END-USER, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY PRODUCT, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY PRODUCT, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY PRODUCT, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY PRODUCT, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY PRODUCT, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY PRODUCT, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY PRODUCT, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY PRODUCT, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY PRODUCT, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY PRODUCT, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY PRODUCT, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY PRODUCT, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY PRODUCT, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY PRODUCT, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY PRODUCT, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY PRODUCT, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY PRODUCT, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY PRODUCT, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY PRODUCT, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY PRODUCT, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY PRODUCT, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY PRODUCT, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY PRODUCT, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY PRODUCT, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY PRODUCT, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY PRODUCT, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY PRODUCT, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY PRODUCT, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY PRODUCT, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY NEUROSCIENCE TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY END-USER, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY PRODUCT, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Neuroscience Technique (USD Billion, 2025-2035)

Neuroimaging
Electrophysiology
Behavioral Neuroscience
Neurogenetics
Computational Neuroscience

Healthcare By Application (USD Billion, 2025-2035)

Neurology
Psychiatry
Addiction Treatment
Drug Discovery
Neuromarketing

Healthcare By End-User (USD Billion, 2025-2035)

Hospitals Clinics
Research Institutions
Pharmaceutical Companies
Biotechnology Companies
Educational Institutions

Healthcare By Product (USD Billion, 2025-2035)

MRI Systems
CT Scanners
PET Scanners
EEG Systems
EMG Systems

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓